Generalized Lipodystrophy (GLD)
1 clinical trials · Condition
◉ Watch Generalized Lipodystrophy (GLD)
| Record | Firm | Date |
|---|---|---|
| Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling (NCT04710056) | Regeneron Pharmaceuticals |
Track Generalized Lipodystrophy (GLD) automatically
Every clearance here is in the API, with alerts when new ones post.